We investigated the developmental regulation of the 13-adrenergic receptor-G,-adenylyl cyclase pathway in myocardial membranes from fetal, neonatal, adult, and mature adult rats by measuring the density of the /3-adrenergic receptor and the activities of the stimulatory guanine nucleotide-binding protein Gs and the adenylyl cyclase enzyme.
Similarly, the level of type V mRNA coding for adenylyl cyclase was greater in the mature adult than in the fetal and neonatal stages. In contrast, the level of type VI adenylyl cyclase mRNA decreased with age, paralleling the decline in the functional activity of adenylyl cyclase with age. Taken together, these data suggest that the age-related changes in the activity of the myocardial f3-adrenergic receptor-G,-adenylyl cyclase pathway is not primarily regulated by alteration in the level of GS or Gi but by the density of f3-adrenergic receptors and by the activity of the catalyst adenylyl cyclase. In particular, steady-state mRNA measurements show that a decrease in the content of the type VI isoform of adenylyl cyclase correlates with a decrease in catalytic activity with age. (Circ Res. 1994;74:596-603.)
Key Words * mRNA * G proteins * adenylyl cyclase isoforms * toxin labeling * immunoblotting * aging ations in the f3-adrenergic receptor-Gs-adenylyl cyclase pathway. 4 Yet the biochemical events that underlie the changing physiological response of the myocardium to catecholamines remain to be fully elucidated. Hormonal activation of the ,B-adrenergic receptor transduction pathway involves at least three proteins: the ,B-adrenergic receptor, the stimulatory guanine nucleotide-binding protein Gs, and adenylyl cyclase.5-7 Thus, alterations in one or more of these proteins could determine the level of intracellular cAMP generation in response to catecholamine stimulation. The activity of adenylyl cyclase can also be modulated by the inhibitory guanine nucleotide-binding protein Gi,8 of which the Gi,a2 iso form predominates in the heart.9.10 Both Gs and Gi are heterotrimeric proteins whose a subunits, on activation, bind and subsequently hydrolyze GTP.11 Although GQa is known to interact directly with adenylyl cyclase, it has been suggested that the inhibition of the effector enzyme could be mediated by the interaction of the "freed" M3y subunits of Gi with the "freed" a subunit of GS12 or possibly by a direct association with the f3y subunit. The first mammalian adenylyl cyclase cDNA was cloned in 1989. 13 Thereafter, mRNA for the type V and VI isoforms of adenylyl cyclase were found to be most abundant in the heart and brain,14-16 thus allowing an examination of the pattern of adenylyl cyclase expression in the heart with development and aging.
In the present study, we investigated alteration in the activity of the cardiac adenylyl cyclase system by measuring individual changes in the level of the f3-adrenergic receptor, GQ, and Gi as well as adenylyl cyclase activity. In addition, we assessed the contribution of the respective steady-state mRNA levels to possible changes in the levels of guanine nucleotide-binding proteins (G proteins) and adenylyl cyclase itself. We followed changes in these protein components in the myocardium of 19-day-old fetuses, 3-day-old neonates, 9- week-old adults, and 9-month-old mature adults.
Materials and Methods
Materials CD rats were purchased from Charles River Laboratories, Inc, Boston, Mass. For the fetal studies, time-mated females were killed after 17 to 19 days of gestation. Neonatal, adult, and mature adult rats were killed at 4 or 5 days, 8 weeks, and 9 months after birth, respectively.
Myocardial Membrane Preparation
Whole fetal hearts were used for the preparation of membranes unless specified. One set of experiments typically required 15 to 20 pregnant female rats, each bearing between 10 and 12 fetuses. Only the ventricles were used in studies of the neonates, adults, and mature adults. Crude membranes were prepared essentially as described by Jones and Besch.17 The hearts were rinsed in ice-cold Krebs-Ringer solution and then homogenized with a Polytron apparatus for 5 seconds in 4 vol of 0.75 mol/L NaCl and 10 mmol/L L-histidine, pH 7.5 (buffer I). The homogenate was centrifuged at 14 000g for 20 minutes, and the resulting pellet was washed twice in buffer I. The pellet was then resuspended in 10 mmol/L NaHCO3 and 5 mmol/L L-histidine, pH 7.5 (buffer II), centrifuged at 14 000g for 20 minutes, homogenized three more times, and recentrifuged. The final pellet was resuspended in 100 mmol/L Tris-HCl, pH 7.4, 5 mmol/L MgCl2, and 1 mmol/L EGTA, frozen in liquid nitrogen, and stored at -80°C. Protein concentration was measured by the method of Lowry et al.18
,3-Adrenergic Receptor Radioligand Binding
Total 83-adrenergic receptor density was assayed in 75 to 100 ,ug of membrane protein for 30 minutes at 37°C in 100 mmol/L Tris-HCl, pH 7.2, 1 mmol/L EGTA, and S mmol/L MgCl2 with '251-cyanopindolol (0.02 to 1.2 nmol/L) in the presence and absence of 2x10-5 mol/L propranolol. Receptor 
Reconstitution of GS Into S49 cyc-Membranes
Reconstitution experiments were performed as an evaluation of GS functional activity21 according to the method used previously in our laboratory.22,23 Briefly, myocardial membranes were solubilized for 1 hour on ice at a concentration of 6 mg/mL in 2% cholate. Myocardial adenylyl cyclase was heat-inactivated for 10 minutes at 37°C. The extract was serially diluted in 0.1% Lubrol, and increasing amounts of solubilized GS were reconstituted with 60 ,ug of S49 cycmembranes in a total volume of 40 ,uL. mmol/L NADP (labeling buffer) in the presence and absence of 10 ,ug/mL pertussis toxin and then labeled for 60 minutes at 30°C. The reaction was stopped by the addition of an equal volume of electrophoresis buffer, and the proteins were resolved on a 13% SDS-polyacrylamide gel. 25 The molar amount of incorporated label was calculated from the radioactivity contained in the labeled band. Nonspecific labeling was determined in the absence of pertussis toxin.
Immunoblot Analysis of Gia, The GQ,2 antiserum was raised against a peptide encoding residues 346 to 355 of the carboxyl terminus of GQ,2 (the sequence KNNLKDCGLF). The peptide linked to keyhole limpet hemocyanin carrier protein was used to immunize rabbits. 26 Proteins were subjected to SDS-polyacrylamide gel electrophoresis and electrophoretically transferred to nitrocellulose. The nitrocellulose was incubated with blocking solution (2.5% dry milk, 2.5% bovine serum albumin, 100 mmol/L NaCl, 1 mmol/L EDTA, 10 mmol/L Tris-HCl, pH 7.5, and 1% Nonidet P-40) for 30 minutes at room temperature. Antiserum containing antibodies to the GQ2 peptide was added to the nitrocellulose to a final dilution of 1:100 to 1:1000, and the incubation was allowed to proceed for another 2 hours. The nitrocellulose was then rinsed and incubated with '251-labeled protein A (5 x 105 cpm/mL, Amersham) in blocking solution for 1 hour before being washed and exposed to x-ray film.
Northern Blot Analysis
Total RNA or poly(A)+ RNA was prepared from 0.5 to 1.0 g of frozen tissue with RNAzol (Biotecx) or Fast Track (Invitrogen) by a modification of the method of Chomczynski and Sacchi.27 RNA (10 ,ug) or poly(A)+ RNA (5 jig) was subjected to electrophoresis on a 7.4% formaldehyde-1% agarose gel as previously described9; the RNA was then transferred and UV-crosslinked to nitrocellulose (Stratalinker, Stratagene). The blot was prehybridized in a solution containing 50% formamide, S x standard saline citrate, S x Denhardt's solution, 25 mmol/L NaPO4 (pH 6.5), and 0.25 mg/mL calf thymus DNA at 42°C for 2 hours before the addition of probe. Hybridization was performed at 42°C for 18 hours, followed by washing under increasingly stringent conditions. Various restriction fragments of canine cDNAs encoding for Gsa and Gi,29 or of canine cDNAs encoding for adenylyl cyclase (types V and VI) were used as probes.14'15 The probes were labeled by the multiprimer random-labeling method (Amersham) using [32P]dCTP. These probes recognize the Gs and Gi,a subunit or adenylyl cyclase from a canine or murine source with equal efficiency. RNA was directly quantified by measuring radioactivity with a Betascope (Betagen). As a measure of RNA loading, the blots were hybridized with a 30-mer oligonucleotide specific for the 28S rRNA (human sequence) that codes for a region highly conserved across species28 or with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an internal control for Northern blots using poly(A)+ RNA. The ratio of specific message to loaded total RNA (eg, counts obtained by hybridization with the specific probe versus counts obtained with the 30-mer or with GAPDH) were calculated.
Statistical Analyses
Because the arithmetic values from the radioligand-binding experiments did not follow a normal gaussian distribution, logarithmic values were used. A multifactorial ANOVA was used to analyze the radioligand-binding data. The results from the adenylyl cyclase catalytic activity measurements (mean±SEM) of basal adenylyl cyclase activity and activity seen in response to NaF, isoproterenol with Gpp(NH)p, and forskolin in each of the four age groups showed that the data could be divided into two groups: fetus and neonate versus adult and mature adult; ie, no differences in each of these activities could be shown between the age subgroups of each of these groups (fetus versus neonate and adult versus mature adult). As an example, in the presence of NaF, the activity in the fetus and neonate is 132 and 102 pmol/min per milligram, respectively, whereas the activity of the adult and the mature adult is 77 and 84 pmol/min per milligram, respectively. The same pattern is apparent when one considers the activity of the catalytic unit in the absence (basal) or presence of other agents [isoproterenol plus Gpp(NH)p or forskolin]. It follows that this pattern is maintained if one summed the activities [basal+NaF+Gpp(NH)p/isoproterenol+forskolin]. The activity of adenylyl cyclase therefore falls naturally into two groups: one made up of the two youngest animals, fetus and neonate; and the other, by the two older ones, adult and mature adult. The point is that catalytic unit activity decreases with age. This finding, which is evidenced by the natural numerical division of the data, justifies the grouping of fetus/neonate and adult/ mature adult. Two-way factorial ANOVA with repeated measures on the "type" factor was then performed using the BMDP4v program (BMDP Statistical Software, Inc). and 170.1±30.1 pmol/L. The average number of myocardial /3-adrenergic receptors was greatest in the fetal and neonatal myocardium. Thereafter, the number declined with advancing age, reaching the lowest value in the 9-month-old rat. Results from a representative experiment are shown in Fig 1. Adenylyl Cyclase Activity
Results

P-Adrenergic Receptor Binding
The Table shows basal activity of adenylyl cyclase, the activity after stimulation of the G protein by isoproterenol with Gpp(NH)p, and the activity resulting from the stimulation of postreceptor components by NaF or forskolin. The statistical analysis described in "Materials and Methods" revealed that the fold stimulation of adenylyl cyclase by NaF, isoproterenol with Gpp(NH), or forskolin over basal activity was equally significant for both the fetal/neonatal group and the adult/mature adult group. However, basal, NaF, isoproterenol with Gpp(NH)p, and forskolin-stimulated adenylyl cyclase activities were significantly greater in the fetal/neonatal group than in the adult/mature adult group (P=.008) (Fig 2) .
Since fetal membranes were prepared from whole heart, and neonatal, adult, and mature adult membranes were prepared from ventricle, we also performed the analysis between the neonate and the adult/mature adult group. As shown in Fig 2, isoproterenol with Gpp(NH)p and forskolin-stimulated adenylyl cyclase activities were similarly significantly greater in the neonate than in the adult/mature adult group. Basal and NaF-stimulated adenylyl cyclase activities were higher in the neonate; however, the difference was not significant. These experiments indicated that the diminution in adenylyl cyclase activity in older animals is consistent with postreceptor changes, ie, in the GQ, Gi, and/or catalytic unit proteins. The basal activity of adenylyl cyclase as well as that stimulated by agents that bypass the f8-adrenergic receptor was assayed as indicated in the same preparation of myocardial membrane used to determine f3-adrenergic receptor density shown in Fig 1. Activity of G, by Reconstitution Into S49 cyc-Membranes Functional G, activity was measured by the ability of cholate-solubilized myocardial membranes to reconstitute NaF-sensitive adenylyl cyclase activity to S49 cycmembranes (Fig 3, left) . The average activity of G, from fetal, neonatal, adult, and mature adult myocardial membranes was 1.55 -+0.1, 1.9+0.55 2.6+0.2, and 1.9±0.2 pmol cAMP for 10 minutes per microgram sarcolemma (mean±SEM, n=3), respectively. Statistical analysis of these data by one-way ANOVA showed that there were no significant differences in the activity of G, among the various age groups.
Quantitative Analysis of Gia
Age-related alterations in adenylyl cyclase activity could also be attributed to changes in inhibition of the catalytic unit by the inhibitory guanine nucleotidebinding protein Gi. The level of Gi determined by ADP-ribosylation of its a subunit in the presence of pertussis toxin (Fig 4A) , as well as by immunoblotting ( Fig 4B) , indicates that, unlike Gs, the level of Gi is developmentally regulated. Quantification by pertussis toxin labeling showed the highest amount of Gia in the Lubrol-solubilized membranes from fetal myocardium, containing 0.82±0.07 pmol/mg (n=5), followed by the neonate, containing 0.51±0.10 pmol/mg (n=5), and adult and mature adult, both containing 0.09±0.02 pmol/mg (n=5 and n=6, respectively). The level was significantly lower in the mature adult rat than in the fetus (P<.01) as well as in the neonate (P<.05). Measurement of Gi,2 levels by immunoblotting also showed the hearts of the younger animals to contain significantly greater amounts of Gia2 than the older ones. Northern Blot Analysis of G,. and Gi. mRNA Analysis of the relative levels of Gsa mRNA was performed to determine whether G5, message levels remained constant during aging and corresponded to the activity as determined by the measurements described above (Fig 3, right) . The Gsa probe detected a message of 2.0 kb, corresponding to Gsa mRNA. 29 Hybridization with this probe showed that the level of Gsa mRNA is not developmentally regulated (Fig 3,  right) . The relative ratio of Gsa to 28S rRNA message was 90 for fetal hearts, 91 for neonatal and adult hearts, and 79 for mature adult hearts. In contrast, the mRNA level for Gia was age dependent (maximal at the neonatal stage, Fig 4C) . The 2.5-kb message was detected by hybridization with a canine cDNA probe for Gi,2 described in Reference 9. Northern Blot Analysis of Adenylyl Cyclase Types IV, V, VI, and VII mRNA were examined by analysis of poly(A)+ RNA prepared from rat heart. Types IV and VII mRNA expression were not easily detected even after 24 hours of exposure. However, adenylyl cyclase probes (types V and VI) each detected a principal message of =6 kb corresponding to the adenylyl cyclase mRNA described previously for canine ventricle after overnight exposure.1415 The type V probe also detected a minor component of~=5 kb. The level of type V adenylyl cyclase mRNA was greatest in the mature adult ( Fig SA) . The relative ratio of type V mRNA to GAPDH message was calculated as a fold increase over the fetal value: 1.75±0.03 for neonatal, 1.47±0.22 for adult, and 2.65+0.46 for the mature adult heart (mean±SEM). In contrast, the levels of type VI adenylyl cyclase mRNA paralleled the changes in the functional activity of adenylyl cyclase seen with aging ( Fig SB) . The relative ratio of type VI mRNA to Fig 6, the result was similar. The content of type V mRNA increased with age, whereas that of type VI mRNA decreased with age.
Discussion
An increase, decrease, or no change in /3-adrenergic receptor density has been associated with the aging of the myocardium.30-33 This discordance is likely due to variations in the preparation of myocardial membranes and the grouping of animals by different age groups. 31 In addition, the lack of an appropriate dominator for the normalization of the data from developmental studies makes absolute quantification of measured parameters difficult, if not impossible. Notwithstanding these difficulties, these types of studies should be pursued, especially in light of the significant developmental regulation of certain G proteins and the implication for the coupling efficiency of the f-adrenergic receptor to adenylyl cyclase. In this study of four different age groups, we used the same membrane preparation to study receptor binding, G protein, and adenylyl cyclase activities. We found that ,B-adrenergic receptor density is altered with age, whereas Q,, protein activity is not; ie, the patterns of the changes in the components of this pathway are different, which suggests that the changes observed are neither a reflection of sarcolemmal content nor are they the result of varying cell size and the unknown impact that this might have on the efficiency of a given number of receptors per unit surface area.
The present study shows that age-related changes in /3-adrenergic receptor density accompany the ontogeny of the murine myocardium. Roeske and Wildenthall noted that a decline in myocardial 83-adrenergic receptor density from the late fetal and early neonatal to adult stage occurs in mice in response to a rising concentration of tissue catecholamine coincident with cardiac sympathetic innervation. Our findings indicate that a similar statement can be made concerning the rat, in which developmental changes in norepinephrine concentration are similar to those in the mouse. 34 These observations support the contention that receptor downregulation occurs as an adaptive mechanism maintaining cardiovascular homeostasis as sympathetic innervation of the heart matures. Indeed, there is a clear parallel between the change in /-adrenergic receptor density with age and the reduced adenylyl cyclase responsiveness to catecholamines. In the present study, one should note that isoproterenol-stimulated activity of adenylyl cyclase was decreased to a greater extent than was either basal or NaF-stimulated activity, when the neonate is compared with the mature adult (Table) . Therefore, it appears that the decrease in myocardial /3-adrenergic receptor density has a functional impact on the efficiency of the signaling pathway. Although we did not investigate changes in high-affinity agent binding, it cannot be ruled out that the interaction of the receptor with Gs could be developmentally regulated.
Our data on the adult and mature adult rats also agree with the data of Fan and Banerjee,' who showed a concomitant decline in /-adrenergic receptor density and isoproterenol-stimulated adenylyl cyclase activity in a comparison of myocardium from 3-month-old and 12-month-old rats. Their findings also indicate that a loss of /3-adrenergic receptor density may account, at least in part, for the diminishing activity of this receptor pathway with age. Although various reports differ concerning age-related changes in f3-adrenergic receptor density in the heart, it has been repeatedly shown that the catecholamine-stimulated activity of adenylyl cyclase diminishes with advancing age. 31-33.35 We assessed the functional activity of the postreceptor components of this adrenergic transduction pathway by measuring the potency for activating adenylyl cyclase of NaP, isoproterenol with Gpp(NH)p, and forskolin. Stimulation of adenylyl cyclase by those agents was significantly lower in adult and mature adult rats when compared with fetal and neonatal rats (Fig 2 and Table) . Therefore, the reduction in adenylyl cyclase activity may result from alterations in the activity of Gsa or the catalytic unit itself. Although previous findings have alluded to a decrease in Gs being responsible for diminished adenylyl cyclase activity,31132,35 no direct evidence has been given to date.
The present study demonstrates that G, activity is not significantly affected by age. The lack of change in G, functional activity as assessed by reconstitution argues against this hypothesis. In addition, the lack of change in the steady-state level of GQ, mRNA parallels the findings on its functional activity. Although maximal activation of adenylyl cyclase by forskolin is related to the presence of (<36,37 the absence of age-related changes in G, activity suggests that the primary postreceptor alteration in this transduction pathway occurs at the level of the enzyme adenylyl cyclase. The adenylyl cyclase system of cardiac sarcolemma is subject to dual regulation by muscarinic and p-adrener- ventricle of the adult rat both the level of Gi and the level of the mRNA encoding for Gia2 are decreased in comparison with those in the neonatal ventricle. In the present study, the age-dependent content of myocardial inhibitory G protein does not parallel that of diminished activity of adenylyl cyclase; ie, its level is greatest in the fetal and neonatal hearts, the stages at which adenylyl cyclase activity is greatest. Therefore, it is unlikely that changes in Gia activity contribute to the decreased activity of the catalytic unit with aging. Complementary DNAs encoding a family of adenylyl cyclase have recently been isolated. [13] [14] [15] [16] 39, 40 It has been suggested that the heart contains mRNAs encoding types IV, V, VI, and VII adenylyl cyclase. However, types IV and VII were hardly detected in cardiac tissues by our Northern blot analysis using poly(A)+ RNA (data not shown). The presence of mRNA expression of types IV and VII was originally reported by polymerase chain reaction in rat cardiac tissues. 39, 40 Thus, the steady-state mRNA levels for type IV and type VII adenylyl cyclase isoforms in the heart appear to be significantly lower than those for types V and VI. Types V and VI are expressed in cardiocytes (Y. Ishikawa and C. Homcy, unpublished observation). In the present study, type VI adenylyl cyclase mRNA decreased with age in the heart in a pattern consonant with the functional activity of the enzyme. In contrast, mRNA levels encoding for type V adenylyl cyclase followed an opposite trend, with the highest levels found in the mature adult. These data suggest that the activity of the /l-adrenergic signaling pathway in the heart is dependent on the content of specific isoforms of adenylyl cyclase whose expression is regulated in a developmentally specific manner. Adenylyl cyclase isoforms other than types V and VI, such as types IV and VII, as well as isoforms not yet identified, may also be developmentally regulated and potentially contribute to catalytic activity with age. These patterns may also vary among species. It is also possible that posttranslational modification of the enzyme by various protein kinases may differ in the fetal and neonatal as compared with the adult and mature adult stages. Clear definition of the mechanisms regulating the overall activity of cardiac adenylyl cyclase will have to await the availability of sufficiently sensitive antibodies that would allow direct measurement of the protein content of each isoform in cardiocytes. Unfortunately, reagents that are both sensitive and specific in the quantitation of adenylyl cyclase isoforms are still under development. Nevertheless, the present study demonstrates that adenylyl cyclase isoform expression in the heart is developmentally regulated and that the steady-state mRNA levels for type VI adenylyl cyclase and the functional activity of the enzyme decrease in concert with aging in the rat heart.
Development-dependent changes of the ,B-adrenergic receptor signal transduction pathway have been studied in tissues other than the myocardium including the maturing rat reticulocyte,41 the rabbit liver during neonatal development,42 and 3T3-L1 cells, which can differentiate into adipocytes.43 In the case of the maturing reticulocyte, the stoichiometry of the 13-adrenergic receptor, GQ, and the catalytic unit is maintained, whereas in the adipocyte and liver, developmental alterations in this adrenergic pathway appear to be defined by an receptor to adenylyl cyclase. The data reported in our studies suggest that age-related changes in the function of the myocardial 3-adrenergic receptor signal transduction pathway are determined both by alterations in the activity of the catalytic unit of adenylyl cyclase and by the content of f3-adrenergic receptors available for coupling to Gs. It appears that multiple and tissuespecific mechanisms underlie the alterations in the p-adrenergic receptor signaling pathway that occur with development and aging.
In summary, the present data show that changes in the activity of adenylyl cyclase occurring with age are independent of the activity of the coupling protein Gs.
In fact, the activity of this protein and the steady-state level of the mRNA encoding Gs, are not developmentally regulated. In contrast, the membrane content of the inhibitory protein Gi is age dependent. However, the pattern of a parallel decrease in Gi, and adenylyl cyclase activity with aging indicates that Gi does not contribute to the decline in the functional activity of the myocardial f-adrenergic receptor signal transduction pathway in the maturing animal. Whereas age-related alterations in ,3-adrenergic receptor density clearly affect the efficiency of hormone-stimulated cAMP generation in the rat heart, we suggest that alterations in adenylyl cyclase activity are also importantly determined by the isoform content of the catalyst itself.
